Nuedexta and Ventricular tachycardia - a phase IV clinical study of FDA data

Summary:

Ventricular tachycardia is reported only by a few people who take Nuedexta.

The phase IV clinical study analyzes which people take Nuedexta and have Ventricular tachycardia. It is created by eHealthMe based on reports of 3,330 people who have side effects while taking Nuedexta from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

3,330 people reported to have side effects when taking Nuedexta.
Among them, 2 people (0.06%) have Ventricular tachycardia.

What is Nuedexta?

Nuedexta has active ingredients of dextromethorphan hydrobromide; quinidine sulfate. eHealthMe is studying from 3,367 Nuedexta users for its effectiveness, alternative drugs and more.

What is Ventricular tachycardia?

Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart) is found to be associated with 2,613 drugs and 1,998 conditions by eHealthMe.

Number of Nuedexta and Ventricular tachycardia reports submitted per year:

Could Nuedexta cause Ventricular tachycardia?

Time on Nuedexta when people have Ventricular tachycardia *:

Gender of people who have Ventricular tachycardia when taking Nuedexta *:

female: 50 %
male: 50 %

Age of people who have Ventricular tachycardia when taking Nuedexta *:

Common side effects people have besides Ventricular tachycardia *:

Unresponsive To Stimuli: 1 person, 50.00%
Fall: 1 person, 50.00%
Arrhythmias (irregular heartbeat): 1 person, 50.00%

Common conditions people have *:

Dementia (madness): 1 person, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nuedexta and have Ventricular tachycardia?

Check whether Ventricular tachycardia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .

Related studies

How severe was Ventricular tachycardia and when was it recovered:

Ventricular tachycardia in Nuedexta

Expand to all the drugs that have ingredients of dextromethorphan hydrobromide; quinidine sulfate:

Ventricular tachycardia and drugs with ingredients of dextromethorphan hydrobromide; quinidine sulfate

Alternative drugs to, pros and cons of Nuedexta:

Nuedexta (3,367 reports)

Common Nuedexta side effects:

Death: 260 reports
Fatigue (feeling of tiredness): 228 reports
Drug ineffective: 200 reports
Dizziness: 168 reports
Weakness: 152 reports
Diarrhea: 130 reports
Drowsiness: 125 reports

Browse all side effects of Nuedexta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Ventricular tachycardia treatments and more:

Ventricular tachycardia (24,131 reports)

COVID vaccines that are related to Ventricular tachycardia:

Common drugs associated with Ventricular tachycardia:

How the study uses the data?

The study uses data from the FDA. It is based on dextromethorphan hydrobromide; quinidine sulfate (the active ingredients of Nuedexta) and Nuedexta (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.